NCT00079053View on ClinicalTrials.gov

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 2, 2004

Primary Completion Date

December 9, 2008

Study Completion Date

January 18, 2011

Conditions
Head and Neck Cancer
Interventions
DRUG

erlotinib hydrochloride

PROCEDURE

adjuvant therapy

Trial Locations (2)

N6A 4L6

London Regional Cancer Program, London

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

Sponsors
All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

NCIC Clinical Trials Group

NETWORK